AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 73849
Drug: Levodopa with
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa with benserazide 151 mg/day
Trial: 22307212
Drug: Randomized phase
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized phase II trials assessing systemic cancer therapies
Trial: 29206944
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist
Trial: 15003077
Drug: Paroxetine CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine CR (12.5-37.5 mg/day)
Trial: 11699398
Drug: Early outpatient
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early outpatient supportive care following induction chemotherapy with cytosine arabinoside and an anthracycline.
Trial: 9608962
Drug: Intramuscular midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular midazolam 0.25 mg.kg‐1 plus intramuscular atropine 0.02 mg.kg‐1
Trial: 9608962
Drug: Intranasal saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal saline drops
Trial: 6769420
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antibiotics)
Trial: 4758423
Drug: Practolol 200
RxNorm normalized name: (±)-practolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol 200 mg by mouth at the beginning and end of each dialysis
Trial: 16565634
Drug: Referral care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral care in the VA general internal medicine clinic
Trial: 11270907
Drug: Lorazepam (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (2.5 mg)
Trial: 1822833
Drug: Nisoldipine 10
RxNorm normalized name: nisoldipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 10 mg chronic administration
Trial: 1822833
Drug: Nisoldipine 5
RxNorm normalized name: nisoldipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 5 mg acute administration
Trial: 1822833
Drug: Nisoldipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (5 mg or 10 mg)
Trial: 6798765
Drug: Preparation I
RxNorm normalized name: Wound Care Preparation Irrigation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation I (SH D 356 A) containing 75 micrograms delta 15-d-norgestrel (Gestoden) + 30 micrograms ethinyloestradiol
Trial: 6798765
Drug: Preparation II
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation II (SH D 356 B) containing 75 micrograms d-norgestrel + 30 micrograms ethinyloestradiol
Trial: 30342467
Drug: Control (sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (sufentanil 0.02 μg/kg/h, Group C)
Trial: 23537608
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy services
Trial: 22820898
Drug: Escitalopram 10-mg
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10-mg daily
Trial: 15699018
Drug: Continuous positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous positive airways pressure treatment for 6 months
Trial: 6805791
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics
Trial: 7551301
Drug: 90-microF biphasic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90-microF biphasic waveform with endocardial-subcutaneous array lead system
Trial: 2123355
Drug: Mackerel supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mackerel supplement (135 g per day for 6 weeks)
Trial: 2123355
Drug: Meat (control)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meat (control) paste (135 g per day for 6 weeks)
Trial: 7362089
Drug: Terbutaline tablet
RxNorm normalized name: terbutaline Oral Tablet
DrugBank: Terbutaline (DB00871)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terbutaline tablet (2.5, 3.75, or 5.0 mg depending on weight)
Trial: 7362089
Drug: Terbutaline oral
RxNorm normalized name: terbutaline Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline oral solution (2.5, 3.75, or 5.0 mg depending on weight)
Trial: 18991624
Drug: Rosuvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (10 mg once daily)
Trial: 27865446
Drug: Utrogestan 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Utrogestan 200 mg
Trial: 27865446
Drug: Utrogestan 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Utrogestan 100 mg
Trial: 1962900
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Kabi 2165, Fragmin)
Trial: 1962900
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Kabi 2165, Fragmin) and Conventional low-dose heparin
Trial: 29391018
Drug: 8 weekly
RxNorm normalized name: Weekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 weekly home visits from nursing students
Trial: 26804639
Drug: Buprenorphine Buccal
RxNorm normalized name: buprenorphine Buccal Film
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine Buccal Film (BBUP) 75 µg, 300 µg, 1200 µg (single-dose study)
Trial: 26804639
Drug: Buprenorphine Buccal
RxNorm normalized name: buprenorphine Buccal Film
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine Buccal Film (BBUP) 60 µg, 120 µg, 180 µg, 240 µg BID (multiple-dose study)
Trial: 22723176
Drug: aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin (100 μM)
Trial: 2140489
Drug: Nicorandil 20
RxNorm normalized name: nicorandil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 20 mg
Trial: 2140489
Drug: Nicorandil 40
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 40 mg
Trial: 6237916
Drug: Nicorandil 60
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 60 mg
Trial: 26420334
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg Se-enriched yeast
Trial: 26420334
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg Se-enriched yeast
Trial: 26420334
Drug: 300 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 μg Se-enriched yeast
Trial: 26420334
Drug: Matching placebo-yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching placebo-yeast tablets
Trial: 24281461
Drug: Thalidomide, 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide, 1.5 to 2.5 mg/kg per day for 8 weeks
Trial: 17168490
Drug: Dynastat (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynastat (new selective COX-2 inhibitor)
Trial: 17168490
Drug: Profenid (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Profenid (conventional nonsteroidal anti-inflammatory drug)
Trial: 14531871
Drug: Fragrance-containing solution
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fragrance-containing solution (10 p.p.m. for 2 weeks, then 250 p.p.m. for 2 weeks)
Trial: 14531871
Drug: Both fragrance-containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both fragrance-containing and placebo solutions
Trial: 9124837
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg/kg/day for 3 days)
Trial: 3045781
Drug: Erythromycin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (40 mg/kg/day for 10 days)
Trial: 3479848
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel
Trial: 3548368
Drug: Control (gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (gel only)
Trial: 19169930
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of oxytocin at the onset of the active phase
Trial: 16514097
Drug: Constraint-Induced Movement
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint-Induced Movement therapy (CI therapy)
Trial: 9404405
Drug: L-arginine (L-arg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (L-arg, 625 mg/min x 10 min)
Trial: 9404405
Drug: Deferoxamine (DFX,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferoxamine (DFX, 50 mg/min x 10 min)
Trial: 8371658
Drug: Carbohydrate ingestion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate ingestion (both L-CHO and S-CHO)
Trial: 8371658
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml of sweet placebo (CON)
Trial: 2904367
Drug: Vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.1 mg kg‐1 (single dose)
Trial: 2876574
Drug: Vecuronium 0.015
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.015 mg kg‐1 followed by 0.085 mg kg‐1 (divided doses)
Trial: 2904367
Drug: Atracurium 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.5 mg kg‐1 (single dose)
Trial: 2876574
Drug: Atracurium 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.075 mg kg‐1 followed by 0.425 mg kg‐1 (divided doses)
Trial: 30381400
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Denosumab (DNM) subcutaneously on day 0 and 180
Trial: 30381400
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Denosumab (DNM)
Trial: 23187888
Drug: Standard unlabelled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard unlabelled dose of zidovudine (300 mg)
Trial: 23187888
Drug: Standard unlabelled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard unlabelled dose of tenofovir (300 mg)
Trial: 18690118
Drug: Nicotine cigarette
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine cigarette (0.6 mg)
Trial: 18690118
Drug: Denicotinized cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denicotinized cigarette (0.05 mg)
Trial: 12442929
Drug: Intrauterine papaverine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine papaverine (30 mg)
Trial: 12442929
Drug: Bupivacaine (0.375%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (0.375% 30 mL)
Trial: 12442929
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (30 mL)
Trial: 1657017
Drug: Trazodone (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone (75 mg orally)
Trial: 18486739
Drug: Ustekinumab 45
RxNorm normalized name: USTEKINUMAB 45MG/0.5ML INJ 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 45 mg
Trial: 18832432
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg citalopram (CIT)
Trial: 12214580
Drug: Formoterol fumarate
RxNorm normalized name: Formoterol Fumarate
DrugBank: Formoterol (DB00983)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Formoterol fumarate dihydrate (Oxis) at doses of 4.5, 18, and 54 microg via Turbuhaler
Trial: 12214580
Drug: Salbutamol at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol at doses of 200 and 1800 microg via pressurised metered dose inhaler (pMDI)
Trial: 9862585
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium hydroxide (4.5 g per g elemental iron ingested)
Trial: 2611358
Drug: Co-trimoxazole (CT;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (CT; combination of sulphamethoxazole 800 mg and trimethoprim 160 mg, twice daily for 5 days)
Trial: 976306
Drug: Flutiorex 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutiorex 20 mg orally
Trial: 31673330
Drug: MoodGYM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MoodGYM plus physical treatments
Trial: 31673330
Drug: Physical treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical treatments alone
Trial: 26597311
Drug: 0.50% (6.5mg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50% (6.5mg) DHEA daily for 12 weeks
Trial: 29392574
Drug: Single 300-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 300-mg dose of droxidopa in the fed state
Trial: 29392574
Drug: Single 300-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 300-mg dose of droxidopa in the fasted state
Trial: 29392574
Drug: Norepinephrine levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norepinephrine levels after dose 1 of TID dosing
Trial: 26986171
Drug: Radioiodine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine therapy (3.7, 4.62, and 5.55 GBq)
Trial: 23406027
Drug: Radioiodine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine therapy
Trial: 20594219
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection sclerotherapy
Trial: 1346337
Drug: Early zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early zidovudine therapy (1500 mg per day)
Trial: 8095008
Drug: Early zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early zidovudine therapy
Trial: 27885532
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein supplementation (0.5 g/kg of ideal body weight)
Trial: 23067910
Drug: Enhanced depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced depression care intervention (6-month duration, including problem-solving therapy and/or pharmacotherapy)
Trial: 17522584
Drug: Bbeta15-42 (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bbeta15-42 (2.4 mg/kg, n = 6)
Trial: 17522584
Drug: Random peptide
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Random peptide (control; 2.4 mg/kg, n = 6)
Trial: 10189324
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil concentrate (55% eicosapentaenoic and docosahexaenoic acids) 6 g/d for 3 months and then 3 g/d for 21 months
Trial: 2302950
Drug: Ranitidine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine plus antacids if necessary to maintain gastric pH at greater than or equal to 4
Trial: 427041
Drug: Iron treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron treatment (iron dextran)
Trial: 23359782
Drug: Triple antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antiplatelet therapy (cilostazol, clopidogrel, and aspirin)
Trial: 9710394
Drug: 2 microg
RxNorm normalized name: Beta 2 microglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 microg intrathecal sufentanil in 3 ml preservative-free saline
Trial: 9710394
Drug: 3 microg
RxNorm normalized name: Calcitriol 3 microgram/g cutaneous ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 microg intrathecal sufentanil in 3 ml preservative-free saline
Trial: 9710394
Drug: 5 microg
RxNorm normalized name: Digoxin 125 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 microg intrathecal sufentanil in 3 ml preservative-free saline
Trial: 9710394
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg intrathecal sufentanil in 3 ml preservative-free saline
Trial: 7989940
Drug: Infusional fluorouracil
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Infusional fluorouracil (I‐FU) 1.2 g/m2/d, as a 72‐hour infusion in the first and third weeks of radiation.
Trial: 7989940
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline infusions).
Trial: 7967
Drug: Sulfentanil (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfentanil (0.05 mg initial dose followed by 0.025 mg repeat injections)
Trial: 7967
Drug: Fentanyl (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.5 mg)
Trial: 16887416
Drug: Normal hospital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal hospital diet plus 400 mL oral nutritional supplements
Trial: 9382540
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration with 5-FU (arm B)
Trial: 1590682
Drug: Ceftazidime (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (100 mg/kg/day) plus co-trimoxazole (trimethoprim, 8 mg/kg/day; sulfamethoxazole, 40 mg/kg/day)
Trial: 1590682
Drug: Chloramphenicol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol (100 mg/kg/day) plus doxycycline (4 mg/kg/day) and co-trimoxazole (trimethoprim, 8 mg/kg/day; sulfamethoxazole, 40 mg/kg/day)
Trial: 29626074
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy targeting LDL-C <70 mg/dL
Trial: 29626074
Drug: Standard statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard statin therapy targeting LDL-C 100-120 mg/dL
Trial: 11579272
Drug: Prednisone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (30 mg/day for 2 weeks)
Trial: 9553290
Drug: Intravenous indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous indomethacin (0.2 mg/kg per dose every 12 to 24 hours for three doses)
Trial: 2262233
Drug: Oral indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral indomethacin
Trial: 8067791
Drug: Prednisolone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (2 mg/kg daily for 14 days, then 1 mg/kg on alternate days for 10 weeks)
Trial: 22929636
Drug: Clonidine 150
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 150 mcg
Trial: 30738795
Drug: Vascular endothelial
RxNorm normalized name: Vascular endothelial growth factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vascular endothelial growth factor-targeted therapy
Trial: 21813917
Drug: Q-chews (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Q-chews (4 chews providing 1,000 mg quercetin, 120 mg epigallocatechin 3-gallate, 400 mg isoquercetin, 400 mg each eicosapentaenoic acid and docosahexaenoic acid, 1,000 mg vitamin C, and 40 mg niacinamide)
Trial: 10928305
Drug: ipsapirone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone (20 mg orally)
Trial: 8342392
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (GH), 0.25 IU/kg/week for 6 months (0.125 IU/kg/week during the first month)
Trial: 19690310
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg oral estradiol (daily)
Trial: 16296255
Drug: 0.45% stannous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45% stannous fluoride gel
Trial: 27113945
Drug: Periarticular liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periarticular liposomal bupivacaine injection
Trial: 27113945
Drug: Periarticular injection
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Periarticular injection of bupivacaine/morphine
Trial: 27113945
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection of bupivacaine/morphine
Trial: 22416789
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (oral and written information)
Trial: 18534051
Drug: MAP0004 (orally-inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAP0004 (orally-inhaled DHE)
Trial: 12803268
Drug: Oral fentanyl
RxNorm normalized name: fentanyl Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fentanyl (0.1 mg)
Trial: 12803268
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (5 mg)
Trial: 1893319
Drug: Standard DPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard DPT vaccine
Trial: 1893319
Drug: Modified DPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified DPT vaccine
Trial: 6678824
Drug: Dilazep, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilazep, 300 mg daily
Trial: 6678824
Drug: Acetylsalicylic acid,
RxNorm normalized name: Acetylsalicylic Acid, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid, 100 mg daily or dipyridamole, 300 mg daily
Trial: 30975379
Drug: high DHA
RxNorm normalized name: Fish Oil/Stevia Extract 850 MG-10 MG Oral Packet [COROMEGA CHILD BRAIN & BODY HIGH DHA OMEGA-3]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high DHA multi-nutrient supplement and exercise